MUCOCUTANEOUS LEISHMANIASIS
\mjˌuːkəkjuːtˈe͡ɪni͡əs lɛʃmˈe͡ɪnɪˌasiz], \mjˌuːkəkjuːtˈeɪniəs lɛʃmˈeɪnɪˌasiz], \m_j_ˌuː_k_ə_k_j_uː_t_ˈeɪ_n_iə_s l_ɛ_ʃ_m_ˈeɪ_n_ɪ__ˌa_s_i_z]\
Definitions of MUCOCUTANEOUS LEISHMANIASIS
Sort: Oldest first
-
a form of leishmaniasis endemic in Mexico and Central American and South America; sores are limited to the skin and mucosa
By Princeton University
-
a form of leishmaniasis endemic in Mexico and Central American and South America; sores are limited to the skin and mucosa
By DataStellar Co., Ltd
-
A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.